Up front hepatectomy for metastatic rectal carcinoma - Reversed, liver first approach. Early experience with 15 patients

Neoplasma

Volumn 61, Issue 4, 2014, Pages 447-452

  Straka, M ^a   Skrovina, M ^a   Soumarova, R ^a   Kotasek, R ^a   Burda, L ^a   Vojtek, C ^a  

^a Hospital Novy Jicin   (Czech Republic)

Author keywords

Hepatectomy; Liver first approach; Reversed strategy; Synchronous liver metastases

Indexed keywords

ADJUVANT THERAPY; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DISEASE COURSE; HUMAN; ILEOSTOMY; IMMUNOMODULATION; INFECTION; KIDNEY METASTASIS; LIVER METASTASIS; LIVER RESECTION; MULTIMODALITY CANCER THERAPY; PRIMARY TUMOR; RECTUM CARCINOMA; TREATMENT PLANNING; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 84904384658     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_055     Document Type: Article

References (54)

1. GRUNDMANN RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg 2011; 3: 183-196. http://dx.doi.org/10.4240/wjgs.v3.i12.183
2. TSOULFAS G, PRAMATEFTAKIS MG. Management of rectal cancer and liver metastatic disease: which comes first? Int J SurgOncol 2012; 2012: 196908. http://dx.doi.org/10.1155/2012/196908
3. MENTHA G, MAJNO P, TERRAZ S, Rubbia-Brandt L, GERVAZ P et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumor. Eur J Surg Oncol 2007; 33(Suppl. 2): 76-83. http://dx.doi.org/10.1016/j.ejso.2007.09.016
4. DE JONG MC, VAN DAM RM, MAAS M, BEMELMANS MHA, OLDE DAMINK SWM et al. The liver-first approach for synchronous colorectal liver metastasis: a 5-year singlecentre experience. HPB 2011; 13: 745-752. http://dx.doi.org/10.1111/j.1477-2574.2011.00372.x
5. FAHY BN, FISHER CP. Synchronous resection of colorectal primary and hepatic metastasis. J Gastrointest Oncol 2012; 3: 48-58.
6. LAM VWT, LAURENCE JM, PANG T, JOHNSTON E, Hol-Lands MJ et al. A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases. HPB(2013). [Epub ahead of print] http://dx.doi.org/10.1111/hpb.12083
7. MIRNEZAMI R, MIRNEZAMI AH, CHANDRAKUMARAN K, HILAL MA, PEARCE NW et al. Shortand long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis. HPB (Oxford) 2011; 13: 295-308. http://dx.doi.org/10.1111/j.1477-2574.2011.00295.
8. NEUMANN UP, SEEHOFER D, NEUHAUS P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int 2010; 107: 335-342.
9. NYGARD IE, LASSEN K, KJÆVE J, REVHAUG A. Mortality and survival rates after elective hepatic surgery in a low-volume centre are comparable to those of high-volume centres. ISRN Surg 2012; 2012: 783932. http://dx.doi.org/10.5402/2012/783932
10. REDDY SK, BARBAS AS, TURLEY RS, STEEL JL, TSUNG A et al. A standard definition of major hepatectomy: resection of four or more liver segments. HPB (Oxford) 2011; 13: 494-502. http://dx.doi.org/10.1111/j.1477-2574.2011.00330.
11. VAN DESSEL E, FIERENS K, PATTYN P, Van Nieuwen-Hove Y, BERREVOET F, et al. Defining the optimal therapy sequence in synchronous resectable liver metastases from colorectal cancer: a decision analysis approach. Acta Chir Belg 2009; 109: 317-320.
12. VERHOEF C, VAN DER POOL AE, NUYTTENS JJ, Plant-Ing AS, EGGERMONT AM et al. The "liver-first approach for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 2009; 52: 23-30. http://dx.doi.org/10.1007/DCR.0b013e318197939a
13. MENTHA G, MAJNO PE, ANDRES A, Rubbia-Brandt L, MOREL P et al. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006; 93: 872-878. http://dx.doi.org/10.1002/bjs.5346
14. ANDRES A, TOSO C, ADAM R, BARROSO E, HUBERT C et al. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 2012; 256: 772-8; discussion 778-9. http://dx.doi.org/10.1097/SLA.0b013e3182734423
15. GARAJOVA I, DI GIROLAMO S, DE ROSA F, CORBELLI J, AGOSTINI V et al. Neoadjuvant Treatment in Rectal Cancer: Actual Status. Chemother Res Pract 2011; 2011: 839742. http://dx.doi.org/10.1155/2011/839742
16. SAUER R, FIETKAU R, WITTEKIND C, MARTUS P, RODEL C et al. Adjuvant versus neodajuvant radiochemotherapy for locally advanced rectal cancer. Strahlenther Onkol 2001; 177: 173-181. http://dx.doi.org/10.1007/PL00002396
17. SIEGEL R, BUROCK S, WERNECKE KD, KRETZSCHMAR A, DIETEL M et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer 2009; 9: 50. http://dx.doi.org/10.1186/1471-2407-9-50
18. MENTHA G, ROTH AD, TERRAZ S, GIOSTRA E, GERVAZ P et al. Liver first'approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008; 25: 430-435. http://dx.doi.org/10.1159/000184734
19. HOPT UT, DROGNITZ O, NEEFF H. Timing of resection in patients with colorectal carcinoma and synchronous liver metastases Article in German. Zentralbl Chir 2009; 134: 425-9. http://dx.doi.org/10.1055/s-0029-1224612
20. POULTSIDES GA, SERVAIS EL, SALTZ LB, PATIL S, Ke-Meny NE et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009; 27: 3379-84. http://dx.doi.org/10.1200/JCO.2008.20.9817
21. SCHEER MG, SLOOTS CE, VAN DER WILT GJ, RUERS TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008; 19: 1829-1835. http://dx.doi.org/10.1093/annonc/mdn398
22. JONSSON K, GRONDAHL G, SALO M, TINGSTEDT B, ANDERSSON R. Repeated Liver Resection for Colorectal Liver Metastases: A Comparison with Primary Liver Resections concerning Perioperative and Long-Term Outcome. Gastroenterol Res Pract. 2012; 2012: 568214. http://dx.doi.org/10.1155/2012/568214
23. WEISS MJ, DANGELICA MI. Patient selection for hepatic resection for metastatic colorectal cancer. J Gastrointest Oncol 2012; 3: 3-10.
24. CARPIZO DR, ARE C, JARNAGIN W, DEMATTEO R, FONG Y et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol 2009; 16: 2138-2146. http://dx.doi.org/10.1245/s10434-009-0521-6
25. CARPIZO DR, DANGELICA M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol 2009; 10: 801-809. http://dx.doi.org/10.1016/S1470-2045(09)70081-6
26. ELIAS D, OUELLET JF, BELLON N, PIGNON JP, POCARD M et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003; 90: 567-574. http://dx.doi.org/10.1002/bjs.4071
27. BENOIST S, NORDLINGER B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 2009; 16: 2385-2390. http://dx.doi.org/10.1245/s10434-009-0492-7
28. NORDLINGER B, SORBYE H, GLIMELIUS B, POSTON GJ, SCHLAG PM et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. The Lancet 2008; 371: 1007-1016. http://dx.doi.org/10.1016/S0140-6736(08)60455-9
29. WIESER M, SAUERLAND S, ARNOLD D, SCHMIEGEL W, REINACHER-SCHICK A. Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials. BMC Cancer 2010; 10: 309. http://dx.doi.org/10.1186/1471-2407-10-309
30. ADAM R, BHANGUI P, POSTON G, MIRZA D, NUZZO G et al. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 2010; 252: 774-787. http://dx.doi.org/10.1097/SLA.0b013e3181fcf3e3
31. CAI GX, CAI SJ. Multi-modality treatment of colorectal liver metastases. World J Gastroenterol 2012; 18: 16-24. http://dx.doi.org/10.3748/wjg.v18.i1.16
32. GALLAGHER DJ, ZHENG J, CAPANU M, HAVILAND D, PATY P et al. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases. Ann Surg Oncol 2009; 16: 1844-1851. http://dx.doi.org/10.1245/s10434-009-0348-1
33. HADDAD AJ, BANI HANI M, PAWLIK TM, Cunning-Ham SC. Colorectal liver metastases. Int J Surg Oncol 2011; 2011: 285840. http://dx.doi.org/10.1155/2011/285840
34. LEHMANN K, RICKENBACHER A, WEBER A, Pestaloz-Zi BC, CLAVIEN PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg 2012; 255: 237-247. http://dx.doi.org/10.1097/SLA.0b013e3182356236
35. NANJI S, CLEARY S, RYAN P, GUINDI M, SELVARAJAH S et al. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol 2013; 20: 295-304. http://dx.doi.org/10.1245/s10434-012-2424-1
36. SHAH K, CLARY B. Synchronous colorectal liver metastases: The surgeon as oncologist perspective. Minerva Chir 2013; 68: 49-76.
37. ALOIA T, SEBAGH M, PLASSE M, KARAM V, LEVI F et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24: 4983-90. http://dx.doi.org/10.1200/JCO.2006.05.8156
38. DIMITROULIS D, Nikiteas N, TROUPIS T, PATSOURAS D, SKANDALAKIS P et al. Role of surgery in colorectal liver metastases: Too early or too late? World J Gastroenterol 2010; 16: 3484-3490. http://dx.doi.org/10.3748/wjg.v16.i28.3484
39. KISHI Y, ZORZI D, CONTRERAS CM, MARU DM, Ko-Petz S et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 2010; 17: 2870-6. http://dx.doi.org/10.1245/s10434-010-1166-1
40. NAKANO H, OUSSOULTZOGLOU E, ROSSO E, CASNEDI S, CHENARD-NEU MP et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247: 118-24. http://dx.doi.org/10.1097/SLA.0b013e31815774de
41. ROBINSON SM, WILSON CH, BURT AD, MANAS DM, WHITE SA. Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis. Ann Surg Oncol 2012; 19: 4287-99. http://dx.doi.org/10.1245/s10434-012-2438-8
42. Vautheyj N, PAWLIK TM, RIBERO D, WU TT, ZORZI D et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-72. http://dx.doi.org/10.1200/JCO.2005.05.3074
43. ADAM R, PASCAL G, CASTAING D, AZOULAY D, Del-Vart V et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240: 1052-61; discussion 1061-4. http://dx.doi.org/10.1097/01.sla.0000145964.08365.01
44. REDDY SK, BARBAS AS, CLARY BM. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol 2009; 16: 2395-410. http://dx.doi.org/10.1245/s10434-009-0372-1
45. KHAN AZ, Morris-Stiff G, MAKUUCHI M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2009; 16: 137-144. http://dx.doi.org/10.1007/s00534-008-0016-z
46. SOUBRANE O, BROUQUET A, ZALINSKI S, TERRIS B, BREZAULT C et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 2010; 251: 454-460. http://dx.doi.org/10.1097/SLA.0b013e3181c79403
47. TAMANDL D, KLINGER M, EIPELDAUER S, HERBERGER B, KACZIREK K et al. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 2011; 18: 421-430. http://dx.doi.org/10.1245/s10434-010-1317-4
48. ZORZI D, LAURENT A, PAWLIK TM, LAUWERS GY, VAUTHEY JN et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94: 274-286. http://dx.doi.org/10.1002/bjs.5719
49. REDDY SK, ZORZI D, LUM YW, BARBAS AS, PAWLIK TM et al. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multiinstitutional analysis. Ann Surg Oncol 2009; 16: 1809-19. http://dx.doi.org/10.1245/s10434-008-0181-y
50. MAAS M, Beets-Tan RG, LAMBREGTS DM, Lammer-Ing G, NELEMANS PJ et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011; 29: 4633-40. http://dx.doi.org/10.1200/JCO.2011.37.7176
51. SMITH JD, RUBY JA, GOODMAN KA, SALTZ LB, GULLIEM JG et al. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 2012; 256: 965-72. http://dx.doi.org/10.1097/SLA.0b013e3182759f1c
52. Habr-Gama A, PEREZ RO, NADALIN W, SABBAGA J, RIBEIRO U Jr et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240: 711-7; discus-sion 717-8.
53. JEGATHEESWARAN S, MASON JM, HANCOCK HC, Siri-Wardena AK. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systemic review. JAMA Surg 2013; 148: 385-91. http://dx.doi.org/10.1001/jamasurg.2013.1216
54. DE ROSA A, GOMEZ D, BROOKS A, CAMERON IC. Liverfirst approach for synchronous colorectal liver metastases: is this a justafiable approach? J Hepatobiliary Pancreat Sci 2013; 20: 263-70. http://dx.doi.org/10.1007/s00534-012-0583-x